All terms in GO
| Label | Id | Description |
|---|---|---|
| imaginal disc growth | GO_0007446 | [The increase in mass of imaginal discs by cell proliferation prior to metamorphosis. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that develop into adult structures (legs, antennae, wings, etc.) during metamorphosis from larval to adult form.] |
| GO_0045573 | GO_0045573 | |
| sterigmatocystin catabolic process | GO_0045574 | [The chemical reactions and pathways resulting in the breakdown of sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.] |
| sterigmatocystin metabolic process | GO_0045460 | [The chemical reactions and pathways involving sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.] |
| basophil activation | GO_0045575 | [The change in morphology and behavior of a basophil resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the basophil has specifically bound via IgE bound to Fc-epsilonRI receptors.] |
| granulocyte activation | GO_0036230 | [The change in morphology and behavior of a granulocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.] |
| mast cell activation | GO_0045576 | [The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.] |
| myeloid leukocyte activation | GO_0002274 | [A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.] |
| poly-gamma-glutamate metabolic process | GO_0070500 | [The chemical reactions and pathways involving poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.] |
| regulation of B cell differentiation | GO_0045577 | [Any process that modulates the frequency, rate or extent of B cell differentiation.] |
| regulation of B cell activation | GO_0050864 | [Any process that modulates the frequency, rate or extent of B cell activation.] |
| poly-gamma-glutamate biosynthetic process | GO_0070501 | [The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.] |
| negative regulation of B cell differentiation | GO_0045578 | [Any process that stops, prevents, or reduces the frequency, rate or extent of B cell differentiation.] |
| capsule poly-gamma-glutamate biosynthetic process | GO_0070502 | [The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds, that forms all or part of a bacterial capsule.] |
| positive regulation of B cell differentiation | GO_0045579 | [Any process that activates or increases the frequency, rate or extent of B cell differentiation.] |
| selenium-containing prosthetic group metabolic process | GO_0070503 | [The chemical reactions and pathways involving a prosthetic group that contains selenium, as in the selenium-dependent molybdenum hydroxylases. The selenium atom in the prosthetic group is required for enzymatic function but is labile to a variety of treatments.] |
| selenium compound metabolic process | GO_0001887 | [The chemical reactions and pathways involving compounds that contain selenium, such as selenocysteine.] |
| prosthetic group metabolic process | GO_0051189 | [The chemical reactions and pathways involving a prosthetic group, the non-amino acid portion of certain protein molecules. Prosthetic groups may be inorganic or organic and are usually required for the biological activity of the protein.] |
| selenium-containing prosthetic group biosynthetic process | GO_0070504 | [The chemical reactions and pathways resulting in the formation of a prosthetic group that contains selenium, as in the selenium-dependent molybdenum hydroxylases. The selenium atom in the prosthetic group is required for enzymatic function but is labile to a variety of treatments.] |
| prosthetic group biosynthetic process | GO_0051191 | [The chemical reactions and pathways resulting in the formation of a prosthetic group, the non-amino acid portion of certain protein molecules. Prosthetic groups may be inorganic or organic and are usually required for the biological activity of the protein.] |